- Microbot Medical ( NASDAQ: MBOT ) has acquired the assets of privately-held medical device firm Nitiloop.
- Financial terms of the deal were not disclosed.
- The deal will strengthen Microbot Medical's ( MBOT ) LIBERTY Robotic System portfolio. It covers the U.S. FDA-approved NovaCross family of Microcatheters (NovaCross CTO, NovaCross Xtreme and NovaCross BTK). These medical devices are intended to facilitate the intraluminal placement of conventional and steerable guidewires beyond stenotic lesions.
For further details see:
Microbot Medical acquires Nitiloop, terms undisclosed